Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma.
A Basit KhanCollin W EnglishWilliam C ChenPrazwal AthukuriJames C BayleyVicky L BrandtArya ShettyCaroline C HadleyAbrar ChoudhuryHsiang-Chih LuArif O HarmanciAkdes S HarmanciStephen T MagillDavid R RaleighTiemo J KlischAkash J PatelPublished in: Acta neuropathologica (2023)
Keyphrases